BIT's 16th Annual Congress of International Drug Discovery Science & Technology-China 2018
Highlight

● Designing 40+ Sessions of Scientific Forums, Symposia, Roundtables, Dialogs, Workshops and Training Courses
● Inviting Worldwide Distinguished Experts, Investors, and Decision Makers in the areas of Drug Discovery for the Grand Thought Collision from 50+ Countries
● Shooting for 200+ Oral Presentations and Hot Paper Briefing in whole Spectrum of Drug Discovery Fields
● Gathering 20+ Exhibitors in Cutting-edge Technologies and Novel Bioproducts
● Bringing in 10+ Professional Media Supporters
● Scheduling 5+ Sessions of Business & Career Development, and Talent Search
● Multi-Zones of Poster Show and Exhibitions of New Finding, New IP, New Tech and New Products

Preliminary Program
Stream 1: Masters' Mind Honor Hall
-Vision from the World Leaders in Drug Discovery
Stream 6: Young Pharmacists’ Nexus
-New Champions in Drug Discovery
Stream 2: High-end Dialogue
 -How B & R Can Accelerate Drug Discovery
Stream 7: Projects Matchmaking
-Building an Efficient Achievements Transformation Platform
Stream 3: Breaking Research of Drug Discovery
-Frontier Science & Technology Researchof the Future Drug Discovery
Stream 8: Drug Discovery Bazaar
-Posters and Exhibits
Stream 4: Best Practice in Drug Discovery against Unmet Diseases
-From Drug R & D Pipelines to Market Development
Stream 9: Joyful Commune
-Sharing the Diversities for Common Interests
Stream 5: Industrial Art Gallery
-From From Drug Approval to International Cooperation
Stream 10: IDDST Awards Dinner
-We are Proud of Your Achievements

Edvard Ingjald Moser (born 27 April 1962) is a Norwegian psychologist, neuroscientist, and institute director of the Kavli Institute for Systems Neuroscience and Centre for Neural Computation at the Norwegian University of Science and Technology (NTNU) in Trondheim, Norway. He currently is based at the Max Planck Institute for Neurobiology near Munich, Germany as a visiting researcher.Moser and his wife, May-Britt Moser, were appointed associate professors in psychology and neuroscience at NTNU in 1996. They were instrumental in the establishment of the Centre for the Biology of Memory (CBM) in 2002 and the Institute for Systems Neuroscience in 2007, and have pioneered research on the brain's mechanism for representing space.Moser has won several prizes, many together with May-Britt Moser (his wife and collaborator), including the Louisa Gross Horwitz Prize, and the Karl Spencer Lashley Award. In 2014 they shared the Nobel Prize in Physiology or Medicine with John O'Keefe. Moser also became a foreign associate of the United States National Academy of Sciences in 2014. The prize was awarded for work identifying the cells that make up the positioning system in the brain.

Dr. Hershko is a Professor of Biochemistry at Technion Israel Institute of Technology where his lab studies the regulation of the mitotic checkpoint. In 2004, Hershko was awarded the Nobel Prize in Chemistry with Drs. Ciechanover and Rose for the discovery of ubiquitin-mediated protein degradation. For the past two decades, Hershko has spent his summers at the Marine Biological Laboratory, where he continues to enjoy bench work.

Dr. Eric Westhof is professor of biophysics and structural biochemistry at the University of Strasbourg, France. He is Academician of the French Academy of Sciences, the German Academy of Sciences and the Academy of Europe. He is director of the Institute of Molecular and Cellular Biology of the CNRS where he leads the unit « Architecture & Reactivity of RNA». His research focuses on the relationships between sequences, structures, evolution and functions of RNA molecules using crystallography, bioinformatics, genomics and modeling approaches.

Dr. Zang Hee Cho was the Professor of Radiological Science at University of California at Irvine and the University Professor and Director of the Neuroscience Research Institute, Incheon, Korea since 1985, until he moved to Advanced Institutes of Convergence Technology, Seoul National University. He has been a pioneer in positron emission tomography (PET) and magnetic resonance imaging since the inception of the computerized tomography (CT) in 1972. He was the first one who pioneered world’s first "Ring PET", the first molecular imaging device, in 1975. More recently, he pioneered the first PET-MRI (Proteomics 2008) demonstrating that in vivo human sub-millimeter high resolution molecular imaging is possible and published over one hundred neuroscience and related scientific publications. He has more than 300 peer reviewed scientific publications covering from nuclear physics to neuroscience and published 3 graduate level text books. Among the numerous honors and awards, he was elected as a Member of the US National Academy of Sciences, Institute of Medicine in 1997.

Dr. Zhen Li, Senior Vice President of Chemistry and Non-Clinical Development, leads discovery chemistry, biology, DMPK, CMC and manufacturing at Arrowhead Pharmaceuticals. She is the key inventor of Arrowhead TRiMTMplatform. She has led the discovery and non-clinical development of Arrowhead two clinical candidates ARO-AAT and ARO-HBV, and multiple preclinical candidates, including ARO-ANG3 at Arrowhead. Prior to joining Arrowhead Pharmaceuticals, Dr. Zhen Li held leadership positions at Merck, Schering-Plough and Novartis, and led teams in drug discovery and process development in small molecule pharmaceuticals as well as RNAi therapeutics covering a range of disease areas. She began her pharmaceutical career at Merck where she did research in medicinal chemistry and process development. Dr. Zhen Li received her bachelor of science degree from Peking University and her Ph.D. from Harvard University.

Dr. Dan Zhang was the recipient of US Federal Government Prize for Medical Service Research in 1993, and served as the secretary general of Expert Fellowship for "1000-Plan". He was chairman of Greater China Region, vice president and member of Executive Operation Committee of Quintiles Transnational Corp., the world largest drug CRO company; and then he was the head of clinical development for North American market and global safety assessment at Sigma-Tau Research Inc., the largest drug-maker in Italy. He obtained 6 clinical approvals from FDA and 1 drug marketing certificate during his service in such companies, in which 1 anti-cancer drug was acquired by Nowartis, and 1 anti-heart failure drug acquired by Debiopharm. He is now chairman and CEO of Fountain Medical Development Ltd.

Dr. Jane Wang is the Vice President of Medicinal Chemistry in the Research Service Division, WuXi Apptec Co, based in Shanghai, China. She has played an important role in building and maintaining the company culture and reputation, received multiple awards, highest feedbacks, and recognation from WuXi’s clients and internally.Dr. Jane Wang has accumulated over twenty five years of scientific, managerial, and leadership experience coupled with extensive project, portfolio, and operational management responsibilities. Dr Jane Wang, a senior principal scientist of Pfizer Inc, had led and significantly contributed to several successful drug R&D programs reaching various development stages, successfully invented and brought 7 drug candidates to clinical trials during her career in Pfizer Inc from Feb of 1998 to Feb of 2010. In March of 2010, Dr. Jane Wang joined WuXi Apptec Co, responsible for supporting WuXi customers to conduct drug discovery programs, she has Co-invented and support several clinical candidates for WuXi customers and kept successful track record in identifying new ideas and technologies to research and development. Dr. Wang is strategic and results-oriented with high attention to detail and focus on the bottom line, her scientific capability and dedication in drug discovery have resulted in following accomplishment for her clients: delivered >5 clinical candidates and >20 PCC, supported 2 IND filing, won a risk sharing milestone, received multiple teams’ awards from clients, and resulted in 4 patents as co-inventor. Dr Jane Wang has published 60 patents/patent applicationsand 27 peer reviewed papers during her drug discovery career. Dr. Jane Wang received her PhD from University of Maryland in May of 1995, followed by the Postdoc in NIH and Schering-Plough from June of 1995 to January of 1998.

Dr. Hong Ling, MD, PhD, Qilu Pharmaceuticals
Hong currently services VP of Innovation, Head of Pipeline and Scientific Evaluation at Qilu Pharmaceuticals, one of the largest integrated biopharmaceutical companies in China. Graduated from Zhongshan University Medical School and Wuerzburg University in Germany, Hong practiced as an internist in China, and has been working on disease biology and early drug discovery for 20+ years. He was a research faculty at Harvard Medical School, and alumni of Genzyme, Sanofi, AbbVie and Sanhome Pharmaceuticals (Nanjing) as Principal Scientist, Associate Director, Chief Scientist and Interim CMO, involved in early discovery, translational medicine and clinical development. Hong has published 50+ peer reviewed publications and book chapters, with a focus on apoptosis, NO, ER stress, cell injury and fibrosis.
Keynote Speakers
说明: scientificprogram3_clip_image014.jpg Dr. Edvard I. Moser
Professor, Norwegian University of Science and Technology, Norway
Nobel Prize Laureate in Physiology or Medicine, 2014
Dr. Avram Hershko
Distinguished Professor at the Rappaport Faculty of Medicine at the Technion, Israel
Nobel Prize Laureate in Chemistry, 2004
Dr. Eric Westhof, Academician, Vice President for Research and Doctoral Studies of the University of Strasbourg, France
Dr. Zang Hee Cho, Professor and Member, US National Academy of Medicine, Wsashington DC. USA
Dr. Hong Ling, VP of Innovation, Head of Pipeline and Scientific Evaluation, Qilu Pharmaceuticals, China
说明: scientificprogram3_clip_image008.jpg Dr. Zhen Li, Senior Vice President, Discovery Chemistry and Manufacturing, Arrowhead Pharmaceuticals, Inc., USA
Dr. Dan Zhang, President, Fountain Medical Development Ltd., China
Dr. Jane Wang,
Vice President of Medicinal Chemistry,
WuXi AppTec Co, China
Renowned Speakers
说明: scientificprogram4_clip_image008.jpg Dr. Kathryn Leake, Director, Oncology Solutions, USA 说明: scientificprogram4_clip_image012.jpg Dr. Ming-Hai Wang, Director,  Texas Tech University HSC School of Pharmacy, USA 说明: scientificprogram4_clip_image020.gif Dr. Steven E. Cohen, Executive Director, Daiichi Sankyo, USA
说明: scientificprogram4_clip_image022.jpg Dr. Renata Gomes, Head of Research  Innovation, University of Oxford, UK 说明: scientificprogram4_clip_image032.jpg Dr. Stanley Schwartz, Emeritus Associate Professor CE Of Medicine, University of Pennsylvania, USA 说明: scientificprogram4_clip_image036.jpg Dr. Jean Michel Scherrmann, Professor, Dean of the Faculty of Pharmaceutical and Biological Sciences, University of Paris, France
说明: scientificprogram4_clip_image063.jpg Dr. Jeffrey Hung, Chief Commercial Officer, GM of cGMP Business, Vigene Biosciences, Inc., USA 说明: scientificprogram4_clip_image080.jpg Dr. Janna Hutz, Senior Director,  Eisai AiM Institute, Eisai Inc. USA 说明: scientificprogram4_clip_image065.jpg Dr. Dave Moskowitz, CEO and Chief Medical Officer, GenoMed, Inc., USA
说明: scientificprogram3_clip_image006.jpg Dr. Stefan Scherer, Vice President, Head Early Development, Strategy and Innovation at Novartis, USA 说明: scientificprogram3_clip_image008.jpg Dr. Qiao Li, Associate Professor, University of Ottawa, Canada 说明: scientificprogram3_clip_image014.jpg Dr. Sanjay Garg, Director, Centre for Pharmaceutical Innovation and Development, Australia
Dr. Jeffery Liu, Director, GSK, USA Dr. Stephan O. Krause
Director of QA Technical Support,
AstraZeneca Biologics, USA
Dr. Beat Flühmann
Director
Vifor Pharma Ltd
Switzerland
说明: Mingde-Xia.jpg Dr. Mingde Xia,
Senior Director, Johnson & Johnson Innovation Center AP, China
说明: C:\Users\Administrator\Desktop\timg1.jpg Dr. Chunlin  Chen,  CEO,  Shanghai Medicilon, USA Dr. Irene Caesar,
CEO, MATRIX LTD, Russia
说明: Nursing-2013-Margaret-I-Fitch-8710.jpg Dr. Margaret Isabell Fitch, Professor, University of Toronto, Canada 说明: C:\Users\Administrator\AppData\Local\Temp\1532403980(1).png Dr. Rakesh  Ranjan, Executive Medical Director, Charak Clinical Researc Center, USA Dr. Chin-Ttarng Lin, Professor, National Taiwan University, Taiwan
说明: scientificprogram4_clip_image045.jpg Dr. John Lambert, Corporate Vice President and Chief Medical Officer, PAREXEL International Shanghai, China 说明: scientificprogram4_clip_image053.jpg Dr. Tom Hodge, Director of Antiviral Research, Tamir Biotechnology, USA 说明: scientificprogram4_clip_image057.jpg Dr. Peter L. Nara, President and CEO, Biological Mimetics, Inc., USA
说明: scientificprogram3_clip_image006.jpg Mr. Hakim Mohamed, President and CEO, Once Source Clinical & Management, USA 说明: scientificprogram3_clip_image008.jpg Dr. Marc Cantillon, Chief Medical Officer, Reviva Pharmaceuticals Inc., USA 说明: scientificprogram3_clip_image014.jpg Dr. Raphael Nudelman, Director,  Teva Pharmaceutical Industries Ltd. Israel
说明: scientificprogram3_clip_image016.jpg Dr. Wei Li, Professor and Director of UTCoP Drug Discovery Center, University of Tennessee Health Science Center, USA  说明: scientificprogram3_clip_image020.jpg Dr. Yuxun Wang, Vice President of Biology, Denovo Pharmatech, China 说明: scientificprogram3_clip_image022.jpg  Dr. A. Vieira,  Director
Metabolic Research Lab, Simon Fraser University, Canada
说明: scientificprogram3_clip_image024.jpg Dr. Ken Aoshima, Director of Data Science Laboratory, hhc Data Creation Center, Eisai Co., Ltd. Japan 说明: scientificprogram3_clip_image028.jpg  Dr. Hossein Hosseinkhani, Founder & Chief Scientific Officer, Matrix, Inc., USA 说明: scientificprogram3_clip_image030.jpg Dr. Gerald J. Yakatan, Chairman & CEO, IriSys, LLC,.USA
说明: scientificprogram3_clip_image032.jpg Dr. Juergen Lademann, Professor, Charite - Universitaetsmedizin Berlin, Germany 说明: scientificprogram3_clip_image034.jpg Dr. Anthony W. Coleman, Research Director, University of Lyon, France 说明: scientificprogram3_clip_image038.jpg Dr. Liang Xu, Associate Professor, Beijing Institute of Pharmacology and Toxicology, China
说明: scientificprogram3_clip_image040.jpg Dr. Martin K. Ostermaier, CEO, InterAx Biotech AG, Switzerland 说明: scientificprogram3_clip_image046.jpg Dr. Xiangbing Qi, Director of Chemistry Center, National Institute of Biological Sciences, China 说明: scientificprogram3_clip_image048.jpg Dr. Rony Seger, Professor, Weizmann Institute of Science, Israel
说明: scientificprogram3_clip_image050.jpg Dr. David L. Pompliano, Co-Founder and Chief Scientific Officer, Lodo Therapeutics Corporation, USA 说明: scientificprogram3_clip_image054.jpg Dr. William Fenical, Distinguished Professor, University of California, USA 说明: scientificprogram4_clip_image002.jpg Dr. Arturo Loaiza-Bonilla, Director, Cancer Treatment Centers of America, USA

 


Past Conference Report

BIT's 15th Annual Congress of International Drug Discovery Science and Technology-Japan 2017 (IDDST-Japan 2017) which was held in Hyatt Regency Osaka, Osaka, Japan on July 25-27, achieved a consummation. The theme of this conference is "Dedicated to Accelerating Drug Innovation". Over 400 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are 2010 Nobel Prize Laureate in Chemistry Dr. Ei-ichi Negishi, H. C. Brown Distinguished Professor of Chemistry in Purdue University; Dr. Howard J. Federoff, Vice Chancellor of Health Affairs and Chief Executive Officer of Health System in University of California, Irvine; Dr. Litao Zhang, Vice President of Bristol-Myers Squibb; Dr. Jan Hoflack, Chief Scientific and Operational Officer of Oncodesign SA; Dr. Akiyoshi Suganuma, Group Officer and President of BA-CFU in Medicine Development Center, Eisai Co., Ltd., Dr. David C. Bunton, CEO of REPROCELL Europe Ltd. …etc.

 View More...
Scenery of Jinan

Jinan, capital of Shandong Province, is located on a plain bordering on hilly country at the lower reaches of the Yellow River (Huanghe). Apart from it s beautiful scenery and mild climate, Jinan is known as the "City of Springs." The most scenic spots in Jinan are Daming Lake, Tai San Mountain, Five Dragon Pool and Thousand Buddha Hill.
News Release
Full Program Released 说明: http://www.bitcongress.com/nano2018/images/NEW015.gif
● Call for Supporting Organizations and Media Partners
● Call for Session Chairs and Speakers 
● Call for Exhibitors and Sponsors
Hosting Organizations

Information Research Center of International Talent, SAFEA


Ji'nan Branch of China Council for The Promotion of International Trade


Jinan Innovation Zone
Supporting Organizations
Operating Organizations
Official Travel Agency
Exhibition
Participating Organizations

Amgen, Inc.
Arrowhead Pharmaceuticals Inc.
Eisai Co., Ltd.
ChemDiv, Inc.
University of Queensland
Comenius University
Fountain Medical Development Ltd.,
McGill University
Pharmaron Inc.
Pfizer Inc.
Florida State University
Shanghai Jiaotong University School of Medicine
Leydig, Voit & Mayer, Ltd.
University of Pittsburgh
F. Hoffmann-La Roche
Tactical Therapeutics, Inc.
Leadscope Inc.
AbbVie Deutschland GmbH & Co. KG
Merck KGaA
Genentech, Inc.
Sanofi
Hamamatsu Photonics K.K.
University of Arizona
ChemDiv, Inc
AbMax Biotechnology Inc.
University Hospital Brno and Medical Faculty of Masaryk University
PSMMC, Riyadh
Boehringer Ingelheim Pharma GmbH & Co. KG
Global PKPD & Pharmacometrics, Eli Lilly and Company
Beijing Institute of Pharmacology and Toxicology
Auckland UniVersity
Cyclenium Pharma Inc.
Helmholtz Centre for Infection Research
University of Arizona
Medlab Clinical Pty Ltd.
National Institute of Biological Sciences, Beijing
Quinnipiac University/King Lee PhD, LCC
Novartis Institue of Biomedical Research
IriSys, LLC,
Private Clinic of Dermatovenerology Svidník
Saarland University
Cardiff University

Media Partners

BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609-826, Fax: 0086-411-84796897
Copyright © 2017-2018 BIT Congress Inc.